3D Systems Corporation announced its financial results for the third quarter ended September 30, 2025.
Revenue of $91.2 million driven by sequential growth in hardware printer sales and continued strong growth year-over-year in Medical Technology.
- Regenerative Medicine revenue declined sequentially, primarily due to the achievement of a program milestone in the prior quarter.
- Operating expenses continued to decline, reflecting strong progress on the Company’s cost reduction initiatives executed during the fiscal year.
- Sequential top-line growth of 8% to 10% anticipated in fourth quarter 2025, driven by strengthening sales of new printer systems, increased materials consumption, and an anticipated rise in customer capital expenditures, which often occurs in the last quarter of the fiscal year.
Summary Comments on Results
Dr. Jeffrey Graves, president and CEO of 3D Systems said, “While the macroeconomic conditions remain similar to those of previous quarters, given the extended duration of our customers curtailment of capex spending, we are beginning to see improvements in our key end-markets as we enter the fourth quarter and approach year-end. This, combined with our strong pipeline of new products, positions us well for improved sales, which we expect to increase sequentially by a range of 8% to 10% in the fourth quarter over those in the third quarter. This rise is expected to be driven by our Healthcare business, the Industrial markets, such as aerospace and defense, and, for the first time in several quarters, increased sales into consumer markets. It is in these markets that we have concentrated our new product development efforts and that focus is now expected to yield increasing results. After the seasonal slowing in the third quarter, our personalized health services is expected to deliver strong growth in the fourth quarter and once again deliver double-digit growth for the full 2025 fiscal year. Our dental business, after seeing a slowdown in the first three quarters of the year related to softness in the aligner market, is expected to now stabilize, with incremental growth expected from our new denture product line, where our new monolithic dentures are being very well received. Gross margins are also expected to stabilize, with increased volumes offsetting mix in the short term and tariff headwinds from rising printer sales. While this heavier mix of printers puts pressure on gross margins, it bodes well for future sales of consumables and services as these printers become operational. With our cost savings initiatives on track and markets showing signs of stabilization, we are increasingly optimistic about the future.”
"I am excited to step into the role of interim CFO," said Phyllis Nordstrom. "We remain focused on maintaining financial discipline, continuing to streamline our cost structure and strengthening our balance sheet. Our actions are designed to create a stronger financial foundation that will enable us to invest in future growth while delivering consistent results in a dynamic market environment."
Third Quarter 2025 Results
Total revenue decreased 19% to $91.2 million compared to the prior year period.
Healthcare Solutions revenue decreased22% to $42.8 million compared to the prior year period.
Industrial Solutions revenue decreased16% to $48.5 million compared to the prior year period.
Gross profit margin decreased to 32.3% compared to 36.9% in the prior year period. Non-GAAP gross profit margin decreased to 32.5% compared to 37.6% in the same period last year. These decreases were primarily due to the divestiture of the Geomagic business and lower sales volume.
Net loss attributable to 3D Systems Corporation decreased by $160.6 million to $18.1 million compared to the prior year period. The decrease was primarily related to asset impairment charges in the prior year period as well as lower amortization expense and lower operating expense in the current quarter.
Adjusted EBITDA improved by $3.5 million to a loss of $10.8 million compared to the prior year period primarily driven by reductions in operating expense.
Financial Liquidity
At September 30, 2025, the Company had total cash of $114.2 million, which included cash and cash equivalents of $95.5 million and restricted cash of $18.7 million. The Company had total debt of $122.6 million, net of deferred financing costs. A total of $34.7 million in debt is scheduled to mature in the fourth quarter of 2026, with the remaining $92.0 million maturing in 2030.
Cash and cash equivalents decreased by $75.8 million since December 31, 2024. This decrease resulted primarily from cash used in operations of $73.1 million and cash used in financing activities of $98.3 million, partially offset by cash provided by investing activities of $108.3 million.
Outlook for Fourth Quarter
Revenue for the fourth quarter is expected to reflect sequential growth of 8% to 10% compared to the third quarter. Gross margins and operating expenses are anticipated to remain in line with current levels, consistent with typical seasonal spending activity in the fourth quarter.
Third Quarter 2025 Conference Call and Webcast
The company will host a conference call and simultaneous webcast to discuss these results on November 5, 2025, which may be accessed as follows:
Date: Wednesday, November 5, 2025
Time: 8:30 a.m. Eastern Time
Listen via webcast: www.3dsystems.com/investor
Participate via telephone: 877-407-8291 or 201-689-8345
A replay of the webcast will be available approximately two hours after the live presentation at www.3dsystems.com/investor.
